Total Payments
$12,264
2024 Payments
$1,893
Companies
46
Transactions
425
Medicare Patients
10,324
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$10,012 (81.6%)
Gifts$1,419 (11.6%)
Education$732.96 (6.0%)
Consulting$100.00 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,012 | 414 | 81.6% |
| Gift | $1,419 | 1 | 11.6% |
| Education | $732.96 | 9 | 6.0% |
| Consulting Fee | $100.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $2,564 | 108 | $0 (2024) |
| NxThera, Inc. | $1,419 | 1 | $0 (2017) |
| ABBVIE INC. | $1,398 | 57 | $0 (2024) |
| PFIZER INC. | $742.89 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $741.83 | 33 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $620.51 | 18 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $605.57 | 24 | $0 (2024) |
| ACCORD HEALTHCARE, INC. | $407.84 | 11 | $0 (2024) |
| EDAP TECHNOMED INC | $376.60 | 2 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $275.92 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,893 | 64 | Sumitomo Pharma America, Inc. ($458.38) |
| 2023 | $1,377 | 47 | Astellas Pharma US Inc ($400.95) |
| 2022 | $1,349 | 52 | Astellas Pharma US Inc ($379.99) |
| 2021 | $1,182 | 48 | Astellas Pharma US Inc ($549.58) |
| 2020 | $859.50 | 41 | Astellas Pharma US Inc ($275.95) |
| 2019 | $1,114 | 45 | Dendreon Pharmaceuticals LLC ($219.15) |
| 2018 | $1,220 | 55 | Astellas Pharma US Inc ($299.00) |
| 2017 | $3,269 | 73 | NxThera, Inc. ($1,419) |
All Payment Transactions
425 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $176.60 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: UROLOGY | ||||||
| 12/06/2024 | ACCORD HEALTHCARE, INC. | — | Food and Beverage | In-kind items and services | $35.17 | General |
| 12/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: HORMONE THERAPY | ||||||
| 12/02/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | KARL STORZ Endoscopy-America | — | Food and Beverage | In-kind items and services | $30.24 | General |
| 10/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $78.15 | General |
| Category: Oncology | ||||||
| 10/29/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $50.93 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/27/2024 | ACCORD HEALTHCARE, INC. | — | Food and Beverage | In-kind items and services | $94.06 | General |
| 10/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: HORMONE THERAPY | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: HORMONE THERAPY | ||||||
| 10/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Oncology | ||||||
| 09/20/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: UROLOGY | ||||||
| 09/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: HORMONE THERAPY | ||||||
| 09/13/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Oncology | ||||||
| 09/04/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,404 | 5,113 | $1.0M | $371,633 |
| 2022 | 32 | 3,390 | 6,867 | $1.1M | $442,215 |
| 2021 | 29 | 2,521 | 4,398 | $779,257 | $292,344 |
| 2020 | 17 | 2,009 | 3,273 | $557,283 | $196,226 |
Total Patients
10,324
Total Services
19,651
Medicare Billing
$1.3M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 597 | 1,077 | $328,485 | $119,490 | 36.4% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 21 | 1,384 | $256,040 | $91,032 | 35.6% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 134 | 136 | $123,352 | $52,464 | 42.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 88 | 99 | $62,865 | $24,293 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $50,830 | $18,275 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 200 | $43,200 | $14,819 | 34.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 87 | $43,500 | $11,826 | 27.2% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 11 | 81 | $25,434 | $9,644 | 37.9% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 134 | 136 | $19,856 | $7,824 | 39.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 38 | 38 | $14,022 | $5,525 | 39.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 738 | 1,353 | $12,177 | $5,331 | 43.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $9,060 | $3,630 | 40.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 32 | 62 | $5,332 | $2,215 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $4,686 | $1,882 | 40.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 120 | 153 | $4,284 | $1,631 | 38.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 134 | 136 | $4,488 | $877.20 | 19.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 15 | 15 | $3,000 | $876.45 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 549 | 955 | $291,659 | $106,904 | 36.7% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2022 | 16 | 672 | $124,320 | $51,061 | 41.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 116 | 119 | $107,933 | $45,576 | 42.2% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 93 | 1,062 | $75,402 | $36,946 | 49.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 29 | 225 | $119,400 | $32,220 | 27.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 89 | 95 | $59,767 | $23,318 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 142 | 142 | $55,558 | $21,231 | 38.2% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 76 | 264 | $37,224 | $18,446 | 49.6% |
About Dr. Qingwei Yan, M.D
Dr. Qingwei Yan, M.D is a Urology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003995648.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Qingwei Yan, M.D has received a total of $12,264 in payments from pharmaceutical and medical device companies, with $1,893 received in 2024. These payments were reported across 425 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,012).
As a Medicare-enrolled provider, Yan has provided services to 10,324 Medicare beneficiaries, totaling 19,651 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Oakland, CA
- Active Since 11/03/2006
- Last Updated 07/20/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1003995648
Products in Payments
- Rezum (Device) $1,419
- XTANDI (Drug) $1,036
- GEMTESA (Drug) $628.33
- Myrbetriq (Drug) $621.83
- PROVENGE (Drug) $620.51
- LUPRON DEPOT (Drug) $493.91
- MYRBETRIQ (Drug) $446.62
- Xtandi (Drug) $399.20
- ORGOVYX (Drug) $338.21
- ZYTIGA (Drug) $304.09
- BOTOX (Biological) $284.78
- Lupron (Drug) $281.55
- CAMCEVI (Drug) $278.61
- Nubeqa (Drug) $275.92
- KEYTRUDA (Biological) $268.41
- Erleada (Drug) $225.44
- Lupron Depot (Drug) $212.42
- ERLEADA (Drug) $212.30
- LYNPARZA (Drug) $209.31
- ELIGARD (Drug) $199.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Oakland
Chih-Hsin Wen, Md, MD
Urology — Payments: $135,782
Urology $135,782
Dr. Shu Pan, M.d, M.D
Urology — Payments: $16,498
Urology $16,498
Christopher Welty, Md, MD
Urology — Payments: $10,061
Urology $10,061
Dr. Dawud Lankford, M.d, M.D
Urology — Payments: $8,203
Urology $8,203
Dr. Christopher Loftus, M.d, M.D
Urology — Payments: $4,098
Urology $4,098
Phillip Ross, Md, MD
Urology — Payments: $2,539
Urology $2,539